DDrare
Disease
Drug
Target Gene/Pathway
問合せ先
EN
RNA Sequencing
( DrugBank: - / KEGG DRUG: - )
1 disease
告示番号
疾患名
(ページ内リンク)
臨床試験数
84
サルコイドーシス
1
84. サルコイドーシス
臨床試験数
:
149
/
薬物数
:
202
- (
DrugBank
:
78
) /
標的遺伝子数
:
66
-
標的パスウェイ数
:
169
10
50
100
ALL
trials per page:
Showing 1 to 1 of 1 trials
Filter by
Reset
No.
TrialID
Date_
enrollment
Date_
registration
Public_title
Scientific_title
Condition
Intervention
Primary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
Phase
Countries
1
NCT03793439
(
ClinicalTrials.gov
)
May 15, 2019
20190515
2/1/2019
20190102
Tofacitinib Hypothesis-generating, Pilot Study for Corticosteroid-Dependent Sarcoidosis
Tofacitinib Hypothesis-generating, Pilot Study for Corticosteroid-Dependent Sarcoidosis
Sarcoidosis, Pulmonary;Sarcoidosis Lung;Sarcoidosis
Drug: Tofacitinib 5mg Oral Tablet [Xeljanz] 16 week trial;Diagnostic Test: Spirometry;Genetic:
RNA
Sequencing
;Diagnostic Test: Laboratory testing;Drug: Corticosteroid;Drug: Tofacitinib 5mg [Xeljanz] 1 year open-label extension
Drug: Tofacitinib 5mg Oral Tablet [Xeljanz] 16 week trial;Diagnostic Test: Spirometry;Genetic:
RNA
S
...
Oregon Health and Science University
Pfizer
Recruiting
18 Years
89 Years
All
5
Phase 1
United States